NM_001854.4:c.1792-15_1792-10delATGATG
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_001854.4(COL11A1):c.1792-15_1792-10delATGATG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00756 in 1,336,324 control chromosomes in the GnomAD database, including 93 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 49 hom., cov: 0)
Exomes 𝑓: 0.0068 ( 44 hom. )
Consequence
COL11A1
NM_001854.4 intron
NM_001854.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.41
Genes affected
COL11A1 (HGNC:2186): (collagen type XI alpha 1 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Mutations in this gene are associated with type II Stickler syndrome and with Marshall syndrome. A single-nucleotide polymorphism in this gene is also associated with susceptibility to lumbar disc herniation. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 1-103005900-CCATCAT-C is Benign according to our data. Variant chr1-103005900-CCATCAT-C is described in ClinVar as [Benign]. Clinvar id is 291531.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-103005900-CCATCAT-C is described in Lovd as [Benign]. Variant chr1-103005900-CCATCAT-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0138 (2077/150322) while in subpopulation AFR AF= 0.0431 (1765/40982). AF 95% confidence interval is 0.0414. There are 49 homozygotes in gnomad4. There are 987 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 49 AD,AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0138 AC: 2073AN: 150208Hom.: 49 Cov.: 0
GnomAD3 genomes
AF:
AC:
2073
AN:
150208
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00707 AC: 1380AN: 195300Hom.: 23 AF XY: 0.00601 AC XY: 632AN XY: 105128
GnomAD3 exomes
AF:
AC:
1380
AN:
195300
Hom.:
AF XY:
AC XY:
632
AN XY:
105128
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00677 AC: 8031AN: 1186002Hom.: 44 AF XY: 0.00627 AC XY: 3698AN XY: 589506
GnomAD4 exome
AF:
AC:
8031
AN:
1186002
Hom.:
AF XY:
AC XY:
3698
AN XY:
589506
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0138 AC: 2077AN: 150322Hom.: 49 Cov.: 0 AF XY: 0.0135 AC XY: 987AN XY: 73256
GnomAD4 genome
AF:
AC:
2077
AN:
150322
Hom.:
Cov.:
0
AF XY:
AC XY:
987
AN XY:
73256
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
not provided Benign:2
May 21, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Marshall syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Fibrochondrogenesis 1 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Stickler Syndrome, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at